Michael Arensman, Ph.D.
Michael is a dedicated cancer researcher with experience ranging from tumor cell biology to immuno-oncology. Prior to joining Volastra, Michael worked at Pfizer, first as a postdoctoral fellow and then as a senior scientist. There he investigated tumor cell mechanisms of immunosuppression and worked to identify targets that could enhance anti-tumor immunity and increase T cell infiltration into tumors. Michael received his bachelor’s in cell and developmental biology from the University of California, Santa Barbara, and his Ph.D. in cellular and molecular pathology from the University of California, Los Angeles.